Abstract
We present a comprehensive framework which describes the systematic (binary) choice of individuals to either take treatment, or not for any reason, over the course of multiple rounds of mass drug administration (MDA) — which we here here refer to as ‘adherence’ and ‘non-adherence’. This methodology can be fitted to (or informed by) program data as well as manipulated to reproduce the same adherence behaviours of past analyses, and can go beyond past analyses to describe new behaviours that have yet to be considered in the literature. Our model also has a straightforward interpretation and implementation in simulations of mass drug trials for disease transmission studies and forecasts for control through MDA. We demonstrate how our analysis may be implemented to statistically infer adherence behaviour from a dataset by applying our approach to the recent adherence data from the TUMIKIA project, a recent trial of deworming strategies in Kenya. We stratify our analysis according to age and sex, though the framework which we introduce here may be readily adapted to accomodate other categories. Our findings include the detection of past behaviour dependent non-adherence in all age groups to varying degrees of severity and particularly strong non-adherent behaviour of men of ages 30+. We then demonstrate the use of our model in stochastic individual-based simulations by running two example forecasts for elimination in TUMIKIA with the learned adherence behaviour implemented. Our results demonstrate the impact and utility of including non-adherence from real world datasets in simulations.
Author summary Mass drug administration (MDA) is an important tool in prevention of morbidity from various neglected tropical diseases (NTDs). Due to a variety of social and medical reasons, many people will either not be offered or refuse such treatment, and if this behaviour is recurring then control measures may face a challenge to achieving their stated goals. Learning the patterns of individual adherence or non-adherence to MDA control measures for NTDs from real world data followed by their implementation in simulated scenarios is a relatively recent development in the study of NTDs. Past analyses assessing individual adherence have informed the approach we take in this work. However, we have sought to provide a framework which encapsulates as many types of adherence behaviour as possible so that their implementation in modern simulations is streamlined effectively. Our example application to the TUMIKIA data highlights the importance of such a general framework as we find past behaviour dependence that may have been missed by other methods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RJH, JET, MW and RMA gratefully thank the Bill and Melinda Gates Foundation for research grant support via the DeWorm3 (OPP1129535) award to the Natural History Museum in London (http://www.gatesfoundation.org/). The views, opinions, assumptions or any other information set out in this article are solely those of the authors. All authors acknowledge joint Centre funding from the UK Medical Research Council and Department for International Development.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data used were from the TUMIKIA project.